ISRCTN52580708 · RECRUITING
The effectiveness of a supplement containing standardized Cosmos caudatus extract on memory, mood and cognitive-related biomarkers in the ageing population with mild cognitive impairment
This trial is testing whether a daily capsule made from Cosmos caudatus, a Malaysian leafy plant, improves memory, mood, and blood markers linked to thinking in people with mild cognitive impairment. Participants take it for 24 weeks versus a placebo. The source lists no phase, so it is early-stage research, not proven or approved.
Eligibility criteria
Inclusion Criteria: 1. Malaysians aged 50 years and above with body mass index (BMI) 20-30 kg/m² 2. Montreal Cognitive Assessment (MoCA) scores ≤23 3. Have no or very minimal limitations in instrumental activities of daily living (IADL) with a score of ≤1.5 SD from mean norm 4. Objective memory impairment with a score of at least 1.5 SD below the mean average in one or more cognitive test (Rey Auditory Verbal Learning Test (RAVLT) (immediate recall) or Digit Span) 5. Self- and informant-reported memory complaints 6. Able to communicate and understand Malay or English language Exclusion Criteria: 1. Individuals diagnosed with neurodegenerative conditions, severe depression and compulsive substance use 2. Individuals with chronic disease (diabetic patient on medication, chronic kidney disease, hepatitis/liver cirrhosis, cancer) 3. Individuals with physical disability 4. Female participants receiving ongoing hormone replacement therapy (HRT) Functional magnetic resonance imaging (fMRI) subsample: 1. Individuals with ferromagnetic or non-ferrous implanted materials 2. Individuals with claustrophobia 3. Individuals with color blindness
The sponsor's own eligibility wording, lightly reformatted. The study team makes the final eligibility decision — worth discussing with your doctor.
Eligibility criteria as of 2026-09-14
Source: ISRCTN registry, record ISRCTN52580708, retrieved 2026-10-27. Registry text licensed CC BY 4.0.